Overview
Availability
- Dr Andrea Henden is:
- Available for supervision
Works
Search Professor Andrea Henden’s works on UQ eSpace
2024
Journal Article
Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignancies
Lindsay, Daniel, Henden, Andrea, Nelles, Ricky, Elliott, Thomas M. and Collins, Louisa G. (2024). Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignancies. Applied Health Economics and Health Policy. doi: 10.1007/s40258-024-00927-8
2024
Conference Publication
Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse
Swain, Fiona, Burgess, Melinda, Kempe, Sarah, Sabdia, Muhammed B., Henden, Andrea S., Wight, Joel, Hawkes, Eliza A., Mutsando, Howard, Talaulikar, Dipti, Merida de Long, Lilia, Birch, Simone, Wyche, Penelope, Hawula, Zachary, Chowdhury, Rakin, Gandhi, Maher K. and Keane, Colm (2024). Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-199352
2024
Conference Publication
Real World Outcomes of Ruxolitinib Treatment of Steroid Refractory/Dependent Acute Graft Versus Host Disease
Leung, Becky, Butler, Jason, Curley, Cameron, Henden, Andrea S., Hunt, Stewart, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2024). Real World Outcomes of Ruxolitinib Treatment of Steroid Refractory/Dependent Acute Graft Versus Host Disease. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-210424
2024
Conference Publication
Allogeneic Haematopoietic Stem Cell Transplantation Is Safe and Effective for Myeloid Neoplasms with Germline DDX41 Mutation
Nelles, Ricky, Butler, Jason, Curley, Cameron, Henden, Andrea S., Hunt, Stewart, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2024). Allogeneic Haematopoietic Stem Cell Transplantation Is Safe and Effective for Myeloid Neoplasms with Germline DDX41 Mutation. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-209669
2024
Journal Article
Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells
Ekwe, Adaeze Precious, Au, Raymond, Zhang, Ping, McEnroe, Benjamin, Tan, Mei Ling, Saldan, Alda, Henden, Andrea S., Hutchins, Cheryl, Henderson, Ashleigh, Mudie, Kari, Kerr, Keri, Fuery, Madonna, Kennedy, Glen A., Hill, Geoffrey R. and Tey, Siok-Keen (2024). Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells. Cytotherapy, 26 (7), 719-728. doi: 10.1016/j.jcyt.2024.02.023
2024
Journal Article
IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation
Zhang, Ping, Fleming, Peter, Andoniou, Christopher E., Waltner, Olivia G., Bhise, Shruti S., Martins, Jose Paulo, McEnroe, Benjamin A., Voigt, Valentina, Daly, Sheridan, Kuns, Rachel D., Ekwe, Adaeze P., Henden, Andrea S., Saldan, Alda, Olver, Stuart, Varelias, Antiopi, Smith, Corey, Schmidt, Christine R., Ensbey, Kathleen S., Legg, Samuel R.W., Sekiguchi, Tomoko, Minnie, Simone A., Gradwell, Mark, Wagenaar, Irma, Clouston, Andrew D., Koyama, Motoko, Furlan, Scott N., Kennedy, Glen A., Ward, E Sally, Degli-Esposti, Mariapia A. ... Tey, Siok-Keen (2024). IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation. Journal of Clinical Investigation, 134 (7) e174184, 1-15. doi: 10.1172/jci174184
2023
Journal Article
ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease
Hamad, Nada, Bilmon, Ian, Chee, Lynette, Henden, Andrea, Johnston, Anna, Purtill, Duncan, Bajel, Ashish, Tey, Siok‐Keen, Yeung, David, Cole, Theresa, Lewis, Clinton and Butler, Jason (2023). ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease. Internal Medicine Journal, 53 (12), 2319-2329. doi: 10.1111/imj.16255
2023
Conference Publication
Feasibility of prebiotic enteral nutrition provision during allogeneic stem cell transplantation
Andersen, S., Kennedy, G., Banks, M. and Henden, A. (2023). Feasibility of prebiotic enteral nutrition provision during allogeneic stem cell transplantation. 45th ESPEN Congress 2023, Lyon, France, 11-14 September 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.clnesp.2023.09.012
2023
Journal Article
Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia
Wong, Philip, Whiteman, David C., Olsen, Catherine M., Yuan, Yin, Butler, Jason, Curley, Cameron, Durrant, Simon, Henden, Andrea, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2023). Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia. Bone Marrow Transplantation, 59 (1) s41409-023-02138-6, 144-146. doi: 10.1038/s41409-023-02138-6
2023
Journal Article
PET assessment of acute gastrointestinal graft versus host disease
Scott, Ashleigh P., Henden, Andrea, Kennedy, Glen A. and Tey, Siok-Keen (2023). PET assessment of acute gastrointestinal graft versus host disease. Bone Marrow Transplantation, 58 (9), 973-979. doi: 10.1038/s41409-023-02038-9
2023
Conference Publication
Phase 1 clinical trial of CD19 CAR-t cells manufactured at the point-of-care
Hutchins, C.J., Henderson, A., Lynam, E.C., Abaca-Cleopas, M., Harvey, K.J., Acworth, M.C., Leung, C., Barnes, E., Robb, R.J., Mudie, K., O’Donnell, M., Perera, N., Pillai, E. Subramonia, Curley, C., Henden, A., Kennedy, G. and Tey, S. (2023). Phase 1 clinical trial of CD19 CAR-t cells manufactured at the point-of-care. 29th Annual ISCT Meeting, Paris, France, 31 May – 3 June 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/s1465-3249(23)00579-0
2022
Conference Publication
Real-world outcomes with CD19 CAR T-cell therapy for B-cell malignancies in regional/rural Australia: results from the Queensland CAR T-Cell Program
Perera, Nilu, Scott, Ashleigh P., Hunt, Stewart, Curley, Cameron, Tey, Siok-Keen, Butler, Jason, Henden, Andrea S, Pillai, Elango S., Hutchins, Cheryl, Mudie, Kari Louise and Kennedy, Glen A. (2022). Real-world outcomes with CD19 CAR T-cell therapy for B-cell malignancies in regional/rural Australia: results from the Queensland CAR T-Cell Program. 64th ASH Annual Meeting, New Orleans, LA United States, 10-13 December 2022. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2022-168399
2022
Journal Article
High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation
Yuan, Yin, Wong, Philip, Butler, Jason P., Henden, Andrea, Curley, Cameron, Durrant, Simon, Mediwake, Heshani, Morton, A. James, Stewart, Caroline, Subramoniapillai, Elango, Weber, Nicholas, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2022). High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation. Bone Marrow Transplantation, 57 (11), 1-4. doi: 10.1038/s41409-022-01773-9
2021
Journal Article
CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant
Yeh, Albert C., Varelias, Antiopi, Reddy, Anupama, Barone, Sierra M., Olver, Stuart D., Chilson, Kate, Onstad, Lynn E., Ensbey, Kathleen S., Henden, Andrea S, Samson, Luke, Jaeger, Carla A, Bi, Timothy, Dahlman, Kimberly B., Kim, Tae Kon, Zhang, Ping, Degli-Esposti, Mariapia A., Newell, Evan W., Jagasia, Madan H., Irish, Jonathan M., Lee, Stephanie J. and Hill, Geoffrey R. (2021). CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant. Blood, 138 (26), 2874-2885. doi: 10.1182/blood.2020009492
2021
Journal Article
Early Cytomegalovirus Reactivation after Allogenic Bone Marrow Transplantation Is Associated with the Loss of Recipient-Derived Humoral Immunity and Is Reduced By IL-6 Inhibition
Zhang, Ping, Fleming, Peter, Andoniou, Christopher, Martins, Jose Paulo, Saldan, Alda, Kuns, Rachel, McEnroe, Benjamin, Henden, Andrea S, Olver, Stuart, Ekwe, Adaeze, Varelias, Antiopi, Smith, Corey, Schmidt, Christine R, Ensbey, Kathleen S, Boeckh, Michael, Kennedy, Glen A, Degli-Esposti, Mariapia, Hill, Geoff R. and Tey, Siok-Keen (2021). Early Cytomegalovirus Reactivation after Allogenic Bone Marrow Transplantation Is Associated with the Loss of Recipient-Derived Humoral Immunity and Is Reduced By IL-6 Inhibition. Blood, 138 (Supplement 1), 138. doi: 10.1182/blood-2021-146643
2021
Journal Article
IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease
Henden, Andrea S., Koyama, Motoko, Robb, Renee J., Forero, Adriana, Kuns, Rachel D., Chang, Karshing, Ensbey, Kathleen S., Varelias, Antiopi, Kazakoff, Stephen H., Waddell, Nicole, Clouston, Andrew D., Giri, Rabina, Begun, Jakob, Blazar, Bruce R., Degli-Esposti, Mariapia A., Kotenko, Sergei V., Lane, Steven W., Bowerman, Kate L., Savan, Ram, Hugenholtz, Philip, Gartlan, Kate H. and Hill, Geoffrey R. (2021). IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease. Blood, 138 (8), 722-737. doi: 10.1182/blood.2020006375
2021
Conference Publication
Interferon Lambda Protects Gastrointestinal Stem Cells from Acute Gvhd
Henden, Andrea S., Robb, Renee, Forero, Adriana, Kuns, Rachel D., Ensbey, Kathleen S., Chang, Karshing, Varelias, Antiopi, Kazakoff, Stephen H., Waddell, Nic, Clouston, Andrew D., Giri, Rabina, Begun, Jakob, Blazar, Bruce R., Degli-Esposti, Mariapia A., Kotenko, Sergei V., Lane, Steven W., Bowerman, Kate L., Savan, Ram, Hugenholtz, Philip, Gartlan, Kate H. and Hill, Geoffrey (2021). Interferon Lambda Protects Gastrointestinal Stem Cells from Acute Gvhd. 2021 TCT Meetings of ASTCT and CIBMTR, Online, 8-12 February 2021. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s2666-6367(21)00107-x
2021
Journal Article
A phase 3 double-blind study of the addition of tocilizumab versus placebo to cyclosporin/methotrexate GvHD prophylaxis
Kennedy, Glen, Tey, Siok-Keen, Buizen, Luke, Varelias, Antiopi, Gartlan, Kate H., Curley, Cameron, Olver, Stuart, Chang, Karshing, Butler, Jason, Misra, Ashish, Subramoniapillai, Elango, Morton, Anthony, Durrant, Simon, Henden, Andrea S, Moore, John, Ritchie, David S, Gottlieb, David, Cooney, Julian P, Paul, Sanjoy K and Hill, Geoffrey R. (2021). A phase 3 double-blind study of the addition of tocilizumab versus placebo to cyclosporin/methotrexate GvHD prophylaxis. Blood, 137 (14), 1970-1979. doi: 10.1182/blood.2020009050
2021
Journal Article
Infectious complications of CAR T-cell therapy: a clinical update
Stewart, Adam G. and Henden, Andrea S. (2021). Infectious complications of CAR T-cell therapy: a clinical update. Therapeutic Advances in Infectious Disease, 8 204993612110367, 1-11. doi: 10.1177/20499361211036773
2020
Conference Publication
Diverse IL-6 signalling modalities drive pathogenic T cell differentiation and graft-versus-host-disease after allotransplantation
Gartlan, Kate H., Wilkinson, Andrew, Chang, Karshing, Kuns, Rachel D., Henden, Andrea, Minnie, Simone A., Ensbey, Kathleen S., Clouston, Andrew, Zhang, Ping, Koyama, Motoko, Hidalgo, Juan, Rose-John, Stefan, Varelias, Antiopi, Vuckovic, Slavica and Hill, Geoffrey R. (2020). Diverse IL-6 signalling modalities drive pathogenic T cell differentiation and graft-versus-host-disease after allotransplantation. Immunology 2020™ Meeting, Honolulu, HI United States, 8 - 12 May 2020. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.204.supp.87.33
Funding
Current funding
Supervision
Availability
- Dr Andrea Henden is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
For media enquiries about Dr Andrea Henden's areas of expertise, story ideas and help finding experts, contact our Media team: